
January 2007
Effective January 1, 2007:
Notification of the Local Coverage Determination for Oxaliplatin for Injection (Eloxatin™) was published in the November 2005 issue of the Medicare Focus.
Effective for claims with dates of service January 1, 2007 and after, the LCD is updated to include coverage for the following USP DI off label indication:
Advanced/metastatic gastric carcinoma. Oxaliplatin in combination with irinotecan or fluorouracil with leucovorin or folinic acid has demonstrated activity in the treatment of advanced/metastatic gastric carcinoma.
ICD-9 codes 151.0-151.9 have been added for this indication.
A copy of the updated Local Coverage Determination can be found https://www.cahabagba.com. Click on your state for the information you need.